Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04360252 · ClinicalTrials.gov registry record · NA

Gracie Diet for Gastroesophageal Reflux Disease

A NA study of Gastroesophageal Reflux and GERD, sponsored by Johns Hopkins University.

Active
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT04360252 is a NA study of Gastroesophageal Reflux and GERD that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 30 participants, below the 184-participant average among 25 other Gastroesophageal Reflux trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04360252, a NA study of Gastroesophageal Reflux and GERD, is active but no longer recruiting, sponsored by Johns Hopkins University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to learn if dietary changes can help improve gastroesophageal reflux disease (GERD) symptoms. The main question\[s\] it aims to answer whether the Gracie Diet is an option to treat GERD symptoms in individuals wish to discontinue standard doses of PPI and / or H2 receptor antagonists. Participants will be taken off PPI and be placed on the Gracie Diet for 8 weeks. Information about the participants reflux symptoms and GERD health related quality of life will be collected to assess the effect of the diet.

Interventions

  • OTHER Gracie Diet

Study Locations (1)

Maryland

  • Johns Hopkins Bayview Medical Center - Baltimore

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2020-11-13
Est. Completion 2027-12
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT04360252

The ClinicalTrials.gov registry entry for NCT04360252 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 184-participant average among 25 other Gastroesophageal Reflux trials with a reported enrollment target (84% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Gastroesophageal Reflux appearing as the primary indexed condition, and to 1 intervention - of which Gracie Diet is the first listed.

NCT04360252 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT04360252 about?

NCT04360252 is a clinical study titled "Gracie Diet for Gastroesophageal Reflux Disease". The goal of this clinical trial is to learn if dietary changes can help improve gastroesophageal reflux disease (GERD) symptoms. The main question\[s\] it aims to answer whether the Gracie Diet is an option to treat GERD symptoms in individuals wish to discontinue standard doses of PPI and / or H2 r...

What is the current status of trial NCT04360252?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2020-11-13. Estimated completion is 2027-12.

What conditions does trial NCT04360252 study?

This clinical trial studies the following conditions: Gastroesophageal Reflux, GERD.

What interventions are being tested in trial NCT04360252?

The interventions under investigation include: Gracie Diet (OTHER).

Who is sponsoring clinical trial NCT04360252?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04360252 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastroesophageal Reflux

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.